Evidence map›Paper›PMID 41648401›Full record

ArticlebioRxiv : the preprint server for biology2026

Proteomic Profiling of Human Omental and Subcutaneous Adipose Tissue in Individuals with a Broad Range of BMI.

Alex Zelter, Yue Winnie Wen, Michael Riffle, Lindsay C Czuba, Aprajita S Yadav, Jerry Zhu, Jessica M Snyder, Aaron Maurais, Jeffrey LaFrance, Saurabh Khandelwal and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Alex ZelterDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-5331-0577
Yue Winnie WenDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
Michael RiffleDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1633-8607
Lindsay C CzubaDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
Aprajita S YadavDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
Jerry ZhuDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
Jessica M SnyderDepartment of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
Aaron MauraisDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Jeffrey LaFranceDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
Saurabh KhandelwalDepartment of General Surgery, Department of Medicine, University of Washington, Seattle, WA, USA.
Judy Y ChenDepartment of General Surgery, Department of Medicine, University of Washington, Seattle, WA, USA.
Estell WilliamsDepartment of General Surgery, Department of Medicine, University of Washington, Seattle, WA, USA.
Zoe ParrDepartment of General Surgery, Department of Medicine, University of Washington, Seattle, WA, USA.
Daniel KimDepartment of General Surgery, Department of Medicine, University of Washington, Seattle, WA, USA.
Katya B RubinowDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.
Michael J MacCossDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1853-0256
Nina IsoherranenDepartment of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.ORCID 0000-0002-9548-3126

Funding

Pharmacological Sciences SupplementT32GM007750 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 1985 to 2023
$12.6M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7M
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetesU01DK137097 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE, Michael MacCoss · 2023 to 2026
$3.4M
Mechanisms of Regulation of Retinoic Acid HomeostasisR01GM111772 · NIGMS · UNIVERSITY OF WASHINGTON · PI ISOHERRANEN, NINA · 2014 to 2021
$3.0M
Mechanisms of Regulation of Retinoic Acid HomeostasisR01DK143511 · NIDDK · UNIVERSITY OF WASHINGTON · PI Nina Isoherranen · 2025 to 2026
$1.2M
NIDDK NIH HHS R01 DK143511NIDDK NIH HHS T32 DK007247NIDDK NIH HHS U01 DK137097NIGMS NIH HHS R01 GM111772NIGMS NIH HHS R24 GM141156NIGMS NIH HHS T32 GM007750
6 · The paper itself

Abstract

Obesity is a major public health challenge affecting an ever-increasing proportion of the global population. It is associated with numerous comorbidities. Progressive expansion and remodeling of adipose tissue may lead to depot specific changes in adipose tissue biology and energy partitioning. Such changes likely precede the development of obesity-related complications. To facilitate a deeper understanding of adipose tissue biology, a comprehensive and quantitative proteomic dataset at the peptide and protein level is presented. Data-independent acquisition LC-MS/MS data were acquired from matched subcutaneous and omental adipose tissues from metabolically healthy individuals with no comorbidities and covering a wide range of body mass indexes. Adipose tissue samples were collected during elective surgeries and immediately processed for histology or frozen until proteomic analysis. Internal and external quality control systems ensured high quality data. All data presented are available via ProteomeXchange. This dataset will allow new insights into biological changes that evolve with increasing adiposity captured before the onset of comorbidities. Matched sampling across fat depots provides an opportunity to uncover depot-specific physiological signatures.

Indexed as

adiposeBMIcomorbiditiesDIALC-MS/MSObesityomentalsubcutaneous

Identifiers

PMID41648401
PMCPMC12871327

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.